Status:
COMPLETED
Efficacy and Safety of Weak Extremely Low Frequency Electromagnetic Fields in Mild and Moderate Essential Hypertension
Lead Sponsor:
Kyoto University
Conditions:
Essential Hypertension
Eligibility:
All Genders
20-74 years
Phase:
PHASE2
Brief Summary
This study will evaluate the efficacy and safety of weak extremely low frequency electromagnetic fields (ELF-EMF) in mild and moderate essential hypertension.
Eligibility Criteria
Inclusion
- Ages: 20 years to 74 years
- Genders : Both
- The severity of hypertension: mild and moderate (WHO/ISH criteria stage I-II) Systolic blood pressure (SBP) \>/= 140 and/or diastolic blood pressure (DBP)\>/= 90 (untreated hypertension cases)
Exclusion
- Any of the following medical conditions:
- Severe essential hypertension (DBP \>110)
- Secondary or malignant hypertension
- History or symptoms of cerebral vascular disease
- History of myocardial infarction
- History of angina pectoris, atrial fibrillation, heart failure and arrhythmia
- Renal dysfunction (serum creatinine \> 2.1mg/dl)
- Severe hepatic dysfunction
- Uncontrolled diabetes
- Allergy, drug sensitivity or chronic skin disease
- Peptic ulcer disease
- Current pregnancy or lactation
- Depression that needs to be treated
- Hypertension controlled with antihypertensive medication
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00709930
Start Date
December 1 2007
End Date
December 1 2008
Last Update
March 31 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kyoto University Hospital
Kyoto, Kyoto, Japan, 606-8507